Agilent Technologies, Inc. (A) FY2024 Annual P&L / Income Statement

Agilent Technologies, Inc. (A) FY2024 Annual P&L / Income Statement

Income statement for 2023-11-01 through 2024-10-31. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net revenue

6,510,000,000 US dollars

Cost of revenue

2,975,000,000 US dollars

Gross profit (calculated)

3,535,000,000 US dollars

Operating expenses (calculated)

2,047,000,000 US dollars

Income from operations

1,488,000,000 US dollars

Other income (expense), net (calculated)

33,000,000 US dollars

Income before taxes, as reported

1,521,000,000 US dollars

Provision for income taxes

232,000,000 US dollars

Net Income

1,289,000,000 US dollars

Agilent CrossLab - Americas

674,000,000 US dollars

Agilent CrossLab - Asia Pacific

518,000,000 US dollars

Agilent CrossLab - Europe

452,000,000 US dollars

Diagnostics and Genomics - Americas

904,000,000 US dollars

Diagnostics and Genomics - Asia Pacific

240,000,000 US dollars

Diagnostics and Genomics - Europe

507,000,000 US dollars

Life Sciences and Applied Markets - Americas

995,000,000 US dollars

Life Sciences and Applied Markets - Asia Pacific

1,409,000,000 US dollars

Life Sciences and Applied Markets - Europe

811,000,000 US dollars

Research and development

479,000,000 US dollars

Selling, general and administrative

1,568,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.